 |
市场调查报告书
商品编码
1084337
全球宠物癌症治疗市场趋势和预测（2022-2028）：治疗药物类型、宠物类型、给药方式、用途和地区Pet Cancer Therapeutics Market, by Therapy Type, Pet Type, Mode of Administration, Application, and Region - Global Trends, and Forecast, 2022 - 2028 |
||||||
宠物抗癌药市场的增长得益于大量用于治疗淋巴瘤、黑色素瘤等常见疾病的在研药物。私营部门和政府机构共同努力开发犬猫新药也是预测期内推动市场增长的关键因素。另一方面，宠物疾病认知度低、成本高、药物副作用大是製约市场增长的因素。
本报告调查了全球宠物癌症治疗市场，定义和概述了市场，分析了对市场增长、法律和监管环境、管道分析和市场规模变化的各种影响因素。它总结了各个类别的预测、细分/地区/主要国家、竞争环境、主要公司概况等
目录
第 1 章调查目标/先决条件
第二章市场展望
第三章市场动态/法律法规/趋势分析
- 市场动态
- 促进因素
- 抑制器
- 市场机会
- 主要亮点
- 管道分析
- 监管准则
- 宠物癌症预防倡议
- 获批的宠物癌症靶向治疗
- 流行病学
第 4 章全球宠物癌症治疗市场：按治疗类型
- 化疗
- 靶向治疗
- 联合治疗
- 免疫疗法
第 5 章全球宠物癌症治疗市场：按宠物类型
- 猫
- 狗
- 马
第 6 章全球宠物癌症治疗市场：按管理模式
- 口语
- 静脉注射
- 本地
第 7 章全球宠物癌症治疗市场：按用途
- 淋巴瘤
- 肥大细胞癌
- 黑色素瘤
- 乳腺癌和鳞状细胞癌
- 其他
第 8 章全球宠物癌症治疗市场：按地区
- 北美
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第9章竞争态势
- 热图分析
- 市场份额分析（3x3 矩阵）
- 公司简介
- Aratana Therapeutics, Inc.
- AB Science
- Boehringer Ingelheim International GmbH
- Zenoaq
- Morphogenesis, Inc.
- VetDC, Inc.
- Karyopharm Therapeutics, Inc.
- Rhizen Pharmaceuticals SA
- Regeneus Ltd.
- Oasmia Pharmaceuticals AB
- Zoetis
- 分析师观点
第 10 章 章节
The pet cancer therapeutics include chemotherapy drugs, targeted therapies, combination therapies, and immunotherapy vaccines, which are commonly recommended by the veterinary doctors. The drugs are mostly recommended to treat various conditions such as lymphoma, mast cell tumors, fibrosarcoma, hemangiosarcoma, and others. Currently, a wide range of formulations are available in the global market for the treatment of pet cancers, which can be administered in the form of tablets, injections or can be applied topically. Thus, the large variety of treatment options has made it easy for the pets to receive effective cancer treatment suitable to curb the condition.
Market Dynamics
The major factor driving growth of the pet cancer therapeutics market include robust number of pipeline drugs for the treatment of highly prevalent conditions such as lymphoma and melanoma. For instance, in 2021, Aratana Therapeutics received approval from the United States Department of Agriculture (USDA) Center for Veterinary Biologics for canine osteosarcoma vaccine- AT-014 for the treatment of dogs diagnosed with osteosarcoma, one year of age or older. The drug candidate was licensed exclusively from Advaxis, Inc. and is currently in the pivotal trial. Moreover, the private and government organizations such as Veterinary Cancer Society, Petco Foundation, and Animal Cancer Foundation are working together to formulate novel drugs for dogs and cats, which is a major factor expected to propel growth of the pet cancer therapeutics market over the forecast period. However, lack of awareness regarding pet diseases, high cost, and adverse effects of the drugs are the factors restraining pet cancer therapeutics market growth.
Key features of the study:
This report provides in-depth analysis of pet cancer therapeutics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global pet cancer therapeutics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Aratana Therapeutics, Inc., AB Science, Boehringer Ingelheim International GmbH, Zenoaq, Morphogenesis, Inc., VetDC, Inc., Karyopharm Therapeutics, Inc., Rhizen Pharmaceuticals SA, Regeneus Ltd., Oasmia Pharmaceuticals AB, and Zoetis
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global pet cancer therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the pet cancer therapeutics market
Detailed Segmentation:
Global Pet Cancer Therapeutics Market, By Therapy Type:
Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy
Global Pet Cancer Therapeutics Market, By Pet Type:
Cat
Dog
Horse
Global Pet Cancer Therapeutics Market, By Mode of Administration:
Oral
Intravenous
Topical
Global Pet Cancer Therapeutics Market, By Application:
Lymphoma
Mast Cell Cancer
Melanoma
Mammary and Squamous Cell Cancer
Others
Global Pet Cancer Therapeutics Market, By Geography:
North America
By Therapy Type:
Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy
By Pet Type:
Cat
Dog
Horse
By Mode of Administration:
Oral
Intravenous
Topical
By Application:
Lymphoma
Mast Cell Cancer
Melanoma
Mammary and Squamous Cell Cancer
Others
By Country:
U.S.
Canada
Latin America
By Therapy Type:
Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy
By Pet Type:
Cat
Dog
Horse
By Mode of Administration:
Oral
Intravenous
Topical
By Application:
Lymphoma
Mast Cell Cancer
Melanoma
Mammary and Squamous Cell Cancer
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Therapy Type:
Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy
By Pet Type:
Cat
Dog
Horse
By Mode of Administration:
Oral
Intravenous
Topical
By Application:
Lymphoma
Mast Cell Cancer
Melanoma
Mammary and Squamous Cell Cancer
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Therapy Type:
Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy
By Pet Type:
Cat
Dog
Horse
By Mode of Administration:
Oral
Intravenous
Topical
By Application:
Lymphoma
Mast Cell Cancer
Melanoma
Mammary and Squamous Cell Cancer
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Therapy Type:
Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy
By Pet Type:
Cat
Dog
Horse
By Mode of Administration:
Oral
Intravenous
Topical
By Application:
Lymphoma
Mast Cell Cancer
Melanoma
Mammary and Squamous Cell Cancer
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Therapy Type:
Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy
By Pet Type:
Cat
Dog
Horse
By Mode of Administration:
Oral
Intravenous
Topical
By Application:
Lymphoma
Mast Cell Cancer
Melanoma
Mammary and Squamous Cell Cancer
Others
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Aratana Therapeutics, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
AB Science
Boehringer Ingelheim International GmbH
Zenoaq
Morphogenesis, Inc.
VetDC, Inc.
Karyopharm Therapeutics, Inc.
Rhizen Pharmaceutical SA
Regeneus Ltd.
Oasmia Pharmaceuticals AB
Zoetis
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Therapy Type
- Market Snippet, By Pet Type
- Market Snippet, By Mode of Administration
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Key Highlights
- Pipeline Analysis
- Regulatory Guidelines
- Initiatives for Prevention of Pet Cancer
- Approved Targeted Therapies for Pet Cancer
- Epidemiology
4. Global Pet Cancer Therapeutics Market, By Therapy Type, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Targeted Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Combination Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
5. Global Pet Cancer Therapeutics Market, By Pet Type, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Cat
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Dog
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Horse
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
6. Global Pet Cancer Therapeutics Market, By Mode of Administration, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
7. Global Pet Cancer Therapeutics Market, By Application, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Lymphoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Mast Cell Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Melanoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Mammary and Squamous Cell Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
8. Global Pet Cancer Therapeutics Market, By Region, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
- North America
- Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Pet Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Mode of Administration, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Pet Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Mode of Administration, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Pet Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Mode of Administration, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Pet Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Mode of Administration, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Pet Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Mode of Administration, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Pet Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Mode of Administration, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- South Africa
- Central Africa
- North Africa
9. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis (3x3 Matrix)
- Company Profiles
- Aratana Therapeutics, Inc.*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- AB Science
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Boehringer Ingelheim International GmbH
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Zenoaq
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Morphogenesis, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- VetDC, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Karyopharm Therapeutics, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Rhizen Pharmaceuticals SA
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Regeneus Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Oasmia Pharmaceuticals AB
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Zoetis
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Analyst Views
10. Section
- References
- Research Methodology
- About us and Sales Contact
